Cenedella.de

Philman's Pharm: "German Quality, California Ingenuity." Est. 1977


Together Germany

PhilmansPharmLogoB1 - Copy

The license is for importing, producing and distributing medical cannabis in Germany.

Together (TASE: TGDR), which specializes in cultivating and producing medical cannabis, has announced that the German company with which it signed a binding memorandum of understanding to acquire control of it, has received a wholesale commercial license for medications from Germany’s Federal Ministry of Health.The license allows the German company to import, produce and distribute narcotic treatments including medical cannabis, so that when acquisition of control in the German company is completed, Together will be allowed to import and distribute medical cannabis products in Germany from other international enterprises. As Germany is one of the main and largest markets in the medical cannabis market, Together believes that acquiring control of the German company will provide it with a major advantage over its rivals around the world, position it alongside the world’s leading producers and suppliers of medical cannabis, and help fulfill its strategy of creating revenue and profits from several countries worldwide. According to the German company’s declarations, it has reached a distribution agreement with a pharmacy chain, which owns more than 100 pharmacies in Germany.

Together CEO Nissim Bracha said, “Receipt of the license by the German company marks an important milestone for Together because with completion of acquisition of control in it, we will immediately be able to begin commercial operations in Europe. In addition to the license for trading in medical cannabis in Germany, we expect that immediately after signing the agreement to acquire control, we will work to import to Germany medical cannabis products from international enterprises, which we will sell and consolidate a significant foothold of operations that can operate throughout Europe.”

The company’s share price was up 4.58% in early afternoon trading on the TASE.

https://en.globes.co.il/en/article-together-associate-wins-medical-cannabis-license-in-germany-1001259368 


The UN Commission of Narcotic Drugs (CND) will receive the final scheduling recommendations of the World Health Organization (WHO) on cannabis in all forms to the 187 Member States at the United Nations Office on Drugs and Crime (UNODC) headquarters in Vienna, Austria on December 5-7, 2018.

More info here:
==========
Philip J. Cenedella IV
www.cenedella.de
Skype: philip.j.cenedella
Phones:   +49.151.720.17652
+1.888.206.3264 USA

German Tax No.: 38/108/04462

VAT No.:  DE313501847

CONFIDENTIAL COMMUNICATION: E-mails from this individual normally contain confidential and privileged material, and are for the sole use of the intended recipient. Use or distribution by an unintended recipient is prohibited. If you believe that you received this e-mail in error, please delete. Electronic Communications Privacy Act, 18 U.S.C. 2510-2521. Thanks.  Copyright © 2018 GERMAN PATIENT ROUNDTABLE – All Rights Reserved.   ** Your personal data will never be shared with anyone, …never.  The German Patient Roundtable is dedicated to Ras Manos, R.I.P.


LA JOLLA HUMAN TRAFFICKING ACCORDS – November 4, 2011

WHEREAS… modern day slavery exists today in the form of human trafficking and sexual exploitation in greater numbers than at any time in our history.*

sara

WE THE PEOPLE… and the National Association of Human Trafficking Victim Advocates hereby declare:

* All peoples, regardless of race, religion, gender, age, nationality, or social group, have the right to live freely without fear of exploitation.

* Due to the increased demand for minor victims of labor and sexual exploitation, all children are entitled to society’s increased protection.

* Due to the fact that human trafficking is the fastest growing crime in our world today, this issue needs urgent attention and full collaboration among all service providers, law enforcement agencies, media outlets, community leaders, governmental agencies, and citizens.

* Legislation to enhance, and close loopholes, in the current laws against human trafficking need to reflect the severity of this heinous crime.

* Victims of human trafficking and sexual exploitation should be given enhanced professional rehabilitation and healing for the traumatic consequences of their enslavement.

* Increased funding focused on programs that work should be the priority of all government organizations and private sector donors so as to effectively fight the demand for forced slave labor and commercialized sex and to help abolish slavery in our lifetime.

* Recognizing that modern slavery is no longer a hidden tragedy, priority needs to given to educating the public, law enforcement, transportation and service industries, the media, and social service providers on how to help stop it.

* All human traffickers and their clients (those that buy others for sex / those that force others to work in slave conditions) need to know society does not accept this behavior and we are increasing our efforts to stop this madness.

* To today’s victims, and tomorrow’s survivors, please know that we are here to help – call the national hotline at 888-3737-888 or email philcenedella at gmail.com

 

IN CONCLUSION … this La Jolla Human Trafficking Accords document should be freely distributed and promoted throughout the world in order for all peoples to work together to finally end this travesty in our society.
* 2011 U.S. State Department TIP report and the National Association of Attorneys General

dhta

 

 


ABDA: Pharmacies risk penalties for cheap medicinal cannabis flowers.

Patients have been reporting recently about pharmacies that have raised prices for cannabis flos for fear of financial and professional consequences. Specifically, this is about cases from Bavaria, Baden-Württemberg and North Rhine-Westphalia. The Federal Association of German Pharmacists Associations (ABDA) has now confirmed on request that pharmacies that deliver cannabis, without the currently h To fully calculate the surcharges that have been discussed, to risk punishment by the respective state pharmacy chamber. Four simultaneous requests from the pharmacy chambers of Bavaria, Baden-Wuerttemberg, North Rhine-Westphalia (Lippe) and the Federal Chamber of Pharmacists (BAK) have consistently revealed that cannabis currently has to be sold for around 24 euros per gram, if the pharmacies as required by law to the Arnzeimittelpreisverordnung (AmPreisV). https://lnkd.in/dseEk6N wtf 3xcostofblackmarket PhilmansPharmLogoB1 - Copygermany cannabis patientrights #dhv


Chen and Sklar forecast that in Germany alone — a country with a population of 82 million people two which Canadian producers such as Aurora Cannabis and Canopy Growth Corp. are already exporting — the medical marijuana market could potentially produce more than $5 billion in revenue for global cannabis producers.

https://business.financialpost.com/cannabis/cannabis-producers-could-be-chasing-global-market-worth-194-billion-in-seven-years-bmo-report  ….

cropped-sm_logo-cenedella-de1.jpg

There are currently 30,000 medical patients in Germany and an annual legal consumption of 7,200 kilograms. The BMO report arrives at the $5 billion figure primarily based on an  assumption that in seven years, 7.5 per cent of sleep, anxiety and pain prescriptions in Germany will be replaced with medical cannabis, opening up the medical pot market to roughly 26 per cent of the overall population.

“Although prices are currently higher, we are projecting that in seven years, more supply will reduce the average wholesale prices to seven euros per gram,” Chen and Sklar wrote.

The report also predicts the total addressable market if all 28 countries in the European Union legalize cannabis for medical use would be $30 billion in seven years, with another $68 billion if they also legalize recreational cannabis….

Cannabis producers could be chasing global market worth $194 billion in seven years: BMO report

 

 


“It has proven to work,” House Speaker Paul Ryan said of cannabidiol (CBD) on Tuesday, specifying that it “helps reduce seizures.”

paul ryan

The top Republican in the US House has issued a surprise endorsement of a key marijuana ingredient’s medical benefits as well as the uses of industrial hemp.

“It has proven to work,” House Speaker Paul Ryan said of cannabidiol (CBD) on Tuesday, specifying that it “helps reduce seizures.”

“We do this in Wisconsin,” he said, referring to his home state’s limited CBD law. “That that oil, I think works well.”   https://www.bostonglobe.com/news/marijuana/2018/10/30/paul-ryan-touts-benefits-marijuana-ingredient-and-industrial-hemp/0SQkZKDqQETGKBtKRR9k1N/story.html?mc_cid=6d3593b689&mc_eid=cd290ff91e